Literature DB >> 16904752

Evaluating the clinical significance of responses by psychiatric inpatients to the mental health subscales of the SF-36.

Elizabeth A Newnham1, Kate E Harwood, Andrew C Page.   

Abstract

BACKGROUND: The Mental Health subscales of the Medical Outcomes Short Form Questionnaire (SF-36; [Ware, J.E., Snow, K.K., Kosinski, M., Gandek, B., 1993. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center]) are increasingly being used to evaluate treatment outcomes, but data to assess the clinical significance of changes are absent. The present study applied Jacobson and Truax's [Jacobson, N.S., Truax, P. 1991. CLINICAL SIGNIFICANCE: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59, 12-19] criteria for clinical significance to the mental health items of the SF-36.
METHOD: Admission and discharge data were collated from 1830 consecutive inpatients at a psychiatric hospital, using the SF-36, the Depression Anxiety Stress Scale, the Quality of Life Enjoyment and Satisfaction Questionnaire and the clinician-rated Health of the Nation Outcome Scale.
RESULTS: Appropriate improvement cut-off scores for the mental health subscales of the SF-36 are reported, and significant differences were found between outcome groups according to clinically significant improvement. LIMITATIONS: CLINICAL SIGNIFICANCE as a means of assessing outcome should be used with caution in inpatient settings, as further improvement is often expected upon discharge from the hospital.
CONCLUSIONS: Assessing clinically significant improvement is an effective means of measuring treatment outcome in terms of quality of life and symptom improvement in psychiatric care.

Entities:  

Mesh:

Year:  2006        PMID: 16904752     DOI: 10.1016/j.jad.2006.07.001

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  20 in total

1.  Postoperative quality of life and cosmetic outcome between minimally invasive video-assisted thyroidectomy and bilateral axillo-breast approach robotic thyroidectomy: a single center retrospective cohort study.

Authors:  Wei-Hsin Chen; Chih-Yi Chen
Journal:  Updates Surg       Date:  2021-03-23

2.  Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus.

Authors:  Yan-Feng Zou; Jian-Hua Xu; Fa-Ming Pan; Jin-Hui Tao; Sheng-Qian Xu; Hui Xiao; Shuang Liu; Jing Cai; Li Lian; Pei-Ling Chen; De-Guang Wang; Sheng-Xiu Liu; Chun-Mei Liang; Qian-Ling Ye; Guo Tian; Min Wu; Yuan-Yuan Gu; Hai-Feng Pan; Hong Su; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

3.  Percutaneous kyphoplasty for the treatment of spinal metastases.

Authors:  Feng Chen; Yong-Hui Xia; Wen-Zhen Cao; Wei Shan; Yang Gao; B O Feng; Difei Wang
Journal:  Oncol Lett       Date:  2016-01-18       Impact factor: 2.967

4.  Mental health problems and marital disruption: is it the combination of husbands and wives' mental health problems that predicts later divorce?

Authors:  Peter Butterworth; Bryan Rodgers
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05-13       Impact factor: 4.328

5.  Patient perceptions of physical health and bipolar symptoms: The intersection of mental and physical health.

Authors:  Emily E Bernstein; Dustin J Rabideau; Margaret E Gigler; Andrew A Nierenberg; Thilo Deckersbach; Louisa G Sylvia
Journal:  J Affect Disord       Date:  2015-09-30       Impact factor: 4.839

6.  The value of adding the Quality of Life Enjoyment and Satisfaction Questionnaire to outcome assessments of psychiatric inpatients with mood and affective disorders.

Authors:  Madeleine L Hope; Andrew C Page; Geoffrey R Hooke
Journal:  Qual Life Res       Date:  2009-05-06       Impact factor: 4.147

7.  Evaluating the Utility of mHealth ECG Heart Monitoring for the Detection and Management of Atrial Fibrillation in Clinical Practice.

Authors:  Kathleen T Hickey; Angelo B Biviano; Hasan Garan; Robert R Sciacca; Teresa Riga; Kate Warren; Ashton P Frulla; Nicole R Hauser; Daniel Y Wang; William Whang
Journal:  J Atr Fibrillation       Date:  2017-02-28

8.  New risk model is able to identify patients with a low risk of progression in systemic sclerosis.

Authors:  Nina Marijn van Leeuwen; Marc Maurits; Sophie Liem; Jacopo Ciaffi; Nina Ajmone Marsan; Maarten Ninaber; Cornelia Allaart; Henrike Gillet van Dongen; Robbert Goekoop; Tom Huizinga; Rachel Knevel; Jeska De Vries-Bouwstra
Journal:  RMD Open       Date:  2021-05

Review 9.  Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.

Authors:  Jenni Hislop; Temitope E Adewuyi; Luke D Vale; Kirsten Harrild; Cynthia Fraser; Tara Gurung; Douglas G Altman; Andrew H Briggs; Peter Fayers; Craig R Ramsay; John D Norrie; Ian M Harvey; Brian Buckley; Jonathan A Cook
Journal:  PLoS Med       Date:  2014-05-13       Impact factor: 11.069

10.  Health-related quality of life in patients with dual diagnosis: clinical correlates.

Authors:  Irina Benaiges; Gemma Prat; Ana Adan
Journal:  Health Qual Life Outcomes       Date:  2012-09-05       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.